Eagle Pharmaceuticals Inc. (EGRX)

45.14
NASDAQ : Health Technology
Prev Close 43.24
Day Low/High 42.59 / 46.01
52 Wk Low/High 33.80 / 64.94
Avg Volume 184.80K
Exchange NASDAQ
Shares Outstanding 14.86M
Market Cap 642.63M
EPS 1.00
P/E Ratio 42.81
Div & Yield N.A. (N.A)

Latest News

Rules of Biotech Investing Change, and So Must Biotech Investors

Rules of Biotech Investing Change, and So Must Biotech Investors

One big change over the last few years has been the struggle of small concerns to penetrate mass markets even with approved and superior drugs.

Three Biotech Names to Consider

Three Biotech Names to Consider

A look at three names to consider in the biotech and biopharma space.

3 Biotech Values in a Fully Valued Market

3 Biotech Values in a Fully Valued Market

Eagle Pharmaceuticals, Aratana Therapeutics and Progenics Pharmaceuticals show promise.

3 Biotech Values in a Fully Valued Market

3 Biotech Values in a Fully Valued Market

Eagle Pharmaceuticals, Aratana Therapeutics and Progenics Pharmaceuticals show promise ahead.

Oversold Small-Cap Biotech Names

Oversold Small-Cap Biotech Names

I am working incrementally into some small stocks with great long-term value.

Three Health-Care Growth Plays

Three Health-Care Growth Plays

Eagle Pharmaceuticals, Invitae and Celgene should do well this year and are attractively priced.

3 Small-Caps Bucking the Downtrend

3 Small-Caps Bucking the Downtrend

News announcements from these companies are supportive of continued strength.

3 Small-Caps Bucking the Downtrend

3 Small-Caps Bucking the Downtrend

News announcements from these companies is supportive of continued strength.

How to Play It When the FDA Slams Your Stock

How to Play It When the FDA Slams Your Stock

Here are three recent examples of how the patient can profit.

Shark Bites: Join the Momentum Parade

Shark Bites: Join the Momentum Parade

The benefits of following the big movers.

A Mid-Year Look at 4 Best Ideas Picks

A Mid-Year Look at 4 Best Ideas Picks

I still like and own these small-caps.

Biotech Gets a Lifeline

Biotech Gets a Lifeline

Solid earnings and the start of some M&A activity may be just what this sector needs to rise.

2 Small-Cap Biotechs With Big Ambitions

2 Small-Cap Biotechs With Big Ambitions

Inovio Pharmaceuticals and Eagle Pharmaceuticals both boast solid pipelines and sound balance sheets.

Stocks Give Up Some Gains as Oil Tanks

The market has given up a good portion of its early gains in last hour or so, while oil -- which rallied above $41 a barrel earlier today to reach a new 2016 high -- is back near $39.50. JPMorgan Chase has turned bearish on the U.S. dollar and bulli...

Markets Open Higher, But Eagle Pharma Tanks

Markets have opened slightly higher this morning, with some stocks worth calling out. Las Vegas Sands (LVS) is continuing its recent winning streak, as Macquarie boosted outlook for companies that operate casinos in the Chinese gambling hub of Macau...

2 'Rules of the Road' for Biotech Investing

2 'Rules of the Road' for Biotech Investing

Follow these maxims and you should do well in this volatile sector.

BioDelivery Is About to Start Delivering

BioDelivery Is About to Start Delivering

The company cleared an important hurdle last month.

That Was the Week That Was

That Was the Week That Was

Let's review.

Eagle Pharmaceuticals Ready to Soar Again

Eagle Pharmaceuticals Ready to Soar Again

After flying high most of the year, the biopharma company is back on my radar.

Biotech: Partnerships Spell Success

Biotech: Partnerships Spell Success

Bet on small-caps with big-name collaborators.

Ride 'Shotgun' to Avoid Investing Mistakes

Ride 'Shotgun' to Avoid Investing Mistakes

Try small stakes in several sector names to improve your odds. Also, don't trade after hours.

Bears: The Gang That Couldn't Shoot Straight

Bears: The Gang That Couldn't Shoot Straight

They have the ammunition but they keep misfiring in the market.

Bit of a Bounce Brings Sigh of Relief

Uncertainty on Greece prevails, but it could have been worse.

Oblivious Market Keeps Chugging Along

But Greece still holds the potential for a surprise.

It's Yellow Light Time in the Market

It's Yellow Light Time in the Market

Caution should trump fear of missing out on further gains.

Playing Biotechs with the House's Money

Playing Biotechs with the House's Money

Here's how to lock in gains on risky small-cap biotechnology stocks.

Tutor Perini Is Just Too Cheap to Ignore

Tutor Perini Is Just Too Cheap to Ignore

Construction firm should benefit from sector's continuing improvement.